NCT05643261 is a NA clinical trial of Muscle and technique training in ACL Injury, sponsored by Norges idrettshøgskole.

Who is sponsoring NCT05643261?

NCT05643261 is sponsored by Norges idrettshøgskole.

What drugs are being tested in NCT05643261?

Interventions in NCT05643261: Muscle and technique training.

What condition does NCT05643261 study?

NCT05643261 studies ACL Injury.

Is NCT05643261 still recruiting?

NCT05643261 is currently status unknown. Last updated 8 December 2022.

Last reviewed 2022-12-08 · How we verify

NCT05643261

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can a Strength and Technique Intervention Reduce Knee Abduction Moment in Young Female Handball Players

Status unknown NA Last updated 8 December 2022

What this trial tests

NA trial testing Muscle and technique training in ACL Injury in 50 participants. Status unknown.

Timeline

15 August 2022

Primary endpoint
30 November 2022

30 November 2022

Quick facts

Lead sponsor	Norges idrettshøgskole
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	50
Start date	15 August 2022
Primary completion	30 November 2022
Estimated completion	30 November 2022
Sites	1 location across Norway

Drugs / interventions tested

Muscle and technique training

Conditions studied

ACL Injury — all drugs for ACL Injury →

Sponsor

Norges idrettshøgskole

Who can join

Adults 15 to 18, female only, with ACL Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anterior cruciate ligament (ACL) injury constitutes the largest problem in female elite ball/team sport today, due to its relatively high incidence and serious short- and long-term consequences. Especially in handball, these injuries typically occur in actions that are essential for the game, i.e. landings and cutting maneuvers, imposing a challenge for risk reduction strategies. Although knowledge about risk factors is constantly increasing and ACL injury prevention programs have been successful in reducing injuries in rigorous scientific study settings, the real-world injury incidence remains high, and even continues to increase. The purpose of this explorative intervention study is to assess the effect of an eight-week strength and technique training in female handball players and its influence on ACL-specific risk factors, especially knee abduction moment (KAM). The results are compared with a control group that did not do the specially designed technique/muscle training.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Perspectives on usability and adoption of a new ACL injury prevention programme for female handball players: a mixed methods approach.
Mørtvedt AI, Krosshaug T, Petushek EJ. · · 2025 · cited 2× · PMID 39897990 · DOI 10.1136/bmjsem-2024-001965

Verify or expand the search:

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

NCT06529679 — Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction · NA · recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT06524869 — Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction · recruiting
NCT07387939 — ACL Reconstruction in Patients Aged 50 Years and Older · active not recruiting
NCT06194682 — Anterior Cruciate Ligament Study · recruiting

Other Norges idrettshøgskole trials

Trials by the same sponsor.

NCT05792657 — The ABEL Feasibility Study (Adherence, Better Health, Exercise and Life Satisfaction) · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05643261 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norges idrettshøgskole
Last refreshed: 8 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05643261.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing